Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema.
Fuchs
Sabine A
SA
Department of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands.
Meyboom
Ronald H B
RH
van Puijenbroek
Eugène P
EP
Guchelaar
Henk-Jan
HJ
D016907:Adverse Drug Reaction Reporting Systems; D000799:Angioedema / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002908:Chronic Disease; D004311:Double-Blind Method; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D009426:Netherlands / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D011945:Receptors, Angiotensin / Q000627:therapeutic use*; D013777:Tetrazoles / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014944:World Health Organization
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D011945:Receptors, Angiotensin; D013777:Tetrazoles; C081643:candesartan